Please use this identifier to cite or link to this item:
https://observatorio.fm.usp.br/handle/OPI/36254
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor | Sistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP | |
dc.contributor.author | SCHMIDT, Rodrigo | |
dc.contributor.author | RODRIGUES, Clarissa Garcia | |
dc.contributor.author | SCHMIDT, Kelen Heinrich | |
dc.contributor.author | IRIGOYEN, Maria Claudia Costa | |
dc.date.accessioned | 2020-06-01T15:01:36Z | - |
dc.date.available | 2020-06-01T15:01:36Z | - |
dc.date.issued | 2020 | |
dc.identifier.citation | ESC HEART FAILURE, v.7, n.1, p.3-14, 2020 | |
dc.identifier.issn | 2055-5822 | |
dc.identifier.uri | https://observatorio.fm.usp.br/handle/OPI/36254 | - |
dc.description.abstract | To retrieve and assess the available data in the literature about the safety and efficacy of baroreflex activation therapy (BAT) in heart failure with reduced ejection fraction (HFrEF) patients, through a rapid systematic review of clinical studies. Rapid systematic review of literature. Searched electronic databases included PubMed, EMBASE, CENTRAL, Scopus, and Web of Science using Mesh and free terms for heart failure and BAT. No language restriction was used for the searches. We included full peer reviewed publications of clinical studies (randomized or not), including patients with HFrEF undergoing BAT, with or without control group, assessing safety and efficacy outcomes. One reviewer conducted the analysis of the selected abstracts and the full-text articles, performed data extraction, and evaluated the methodological quality of the selected articles. The methodological quality was assessed according to the Cochrane Collaboration instruments. A descriptive summary of the results is provided. Of the 441 citations screened, 10 publications were included (three were only conference abstracts), reporting data from three studies. Only one study was a randomized clinical trial. Two studies reported a 6 month following, and the other study analysed outcomes up to 41 months. The procedure seems to be safe when performed by a well-trained multi-professional team. An 86% rate of system and procedure-related complication-free was reported, with no cranial nerve injuries. Improvements in New York Heart Association class of heart failure, quality of life, 6 min walk test, and hospitalization rates, as well as in muscle sympathetic nerve activity. No meta-analysis was conducted because of the lack of homogeneity across studies; the results from each study are reported individually. BAT procedure seems to be safe if appropriate training is provided. Improvements in clinical outcomes were described in all included studies. However, several limitations do not allow us to make conclusive statements on the efficacy of BAT for HFrEF. New well-designed trials are still needed. | eng |
dc.language.iso | eng | |
dc.publisher | WILEY PERIODICALS, INC | eng |
dc.relation.ispartof | Esc Heart Failure | |
dc.rights | openAccess | eng |
dc.subject | Baroreflex activation therapy | eng |
dc.subject | Heart failure | eng |
dc.subject | Rapid review | eng |
dc.subject.other | baroreceptor activation | eng |
dc.title | Safety and efficacy of baroreflex activation therapy for heart failure with reduced ejection fraction: a rapid systematic review | eng |
dc.type | article | eng |
dc.rights.holder | Copyright WILEY PERIODICALS, INC | eng |
dc.identifier.doi | 10.1002/ehf2.12543 | |
dc.identifier.pmid | 31965746 | |
dc.subject.wos | Cardiac & Cardiovascular Systems | eng |
dc.type.category | review | eng |
dc.type.version | publishedVersion | eng |
hcfmusp.author.external | RODRIGUES, Clarissa Garcia:Global Res & Innovat Network GRINN, Joinville, SC, Brazil | |
hcfmusp.author.external | SCHMIDT, Kelen Heinrich:Nova Southeastern Univ, Inst Neuroimmune Med, Ft Lauderdale, FL 33314 USA | |
hcfmusp.description.beginpage | 3 | |
hcfmusp.description.endpage | 14 | |
hcfmusp.description.issue | 1 | |
hcfmusp.description.volume | 7 | |
hcfmusp.origem | WOS | |
hcfmusp.origem.id | WOS:000509492600001 | |
hcfmusp.origem.id | 2-s2.0-85078749743 | |
hcfmusp.publisher.city | SAN FRANCISCO | eng |
hcfmusp.publisher.country | USA | eng |
hcfmusp.relation.reference | Abraham WT, 2015, JACC-HEART FAIL, V3, P487, DOI 10.1016/j.jchf.2015.02.006 | eng |
hcfmusp.relation.reference | Ad N, 2016, SEMIN THORAC CARDIOV, V28, P329, DOI 10.1053/j.semtcvs.2016.08.009 | eng |
hcfmusp.relation.reference | Ambrosy AP, 2014, J AM COLL CARDIOL, V63, P1123, DOI 10.1016/j.jacc.2013.11.053 | eng |
hcfmusp.relation.reference | [Anonymous], 2018, PROSPERO | eng |
hcfmusp.relation.reference | Floras JS, 2009, J AM COLL CARDIOL, V54, P375, DOI 10.1016/j.jacc.2009.03.061 | eng |
hcfmusp.relation.reference | Go AS, 2014, CIRCULATION, V129, pe28 | eng |
hcfmusp.relation.reference | Grassi G, 2009, HYPERTENSION, V54, P690, DOI 10.1161/HYPERTENSIONAHA.108.119883 | eng |
hcfmusp.relation.reference | Gronda E, 2018, 4 YEARS BAROREFLEX A | eng |
hcfmusp.relation.reference | Gronda E, 2016, CLIN RES CARDIOL, V105, P838, DOI 10.1007/s00392-016-0992-y | eng |
hcfmusp.relation.reference | Gronda E, 2015, J HYPERTENS, V33, P1704, DOI 10.1097/HJH.0000000000000603 | eng |
hcfmusp.relation.reference | Gronda E, 2014, EUR J HEART FAIL, V16, P977, DOI 10.1002/ejhf.138 | eng |
hcfmusp.relation.reference | Halbach M, 2018, INT J CARDIOL, V266, P187, DOI 10.1016/j.ijcard.2018.04.075 | eng |
hcfmusp.relation.reference | Halbach Marcel, 2016, Curr Heart Fail Rep, V13, P71, DOI 10.1007/s11897-016-0286-8 | eng |
hcfmusp.relation.reference | Halbach M, 2014, EXPERT REV CARDIOVAS, V12, P1465, DOI 10.1586/14779072.2014.979790 | eng |
hcfmusp.relation.reference | Higgins JPT, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5928 | eng |
hcfmusp.relation.reference | Hoppe UC, 2012, J AM SOC HYPERTENS, V6, P270, DOI 10.1016/j.jash.2012.04.004 | eng |
hcfmusp.relation.reference | Moher D, 2010, INT J SURG, V8, P336, DOI 10.1016/j.ijsu.2010.02.007 | eng |
hcfmusp.relation.reference | Mueller-Ehmsen J, 2018, EUROPEAN EXPERIENCE | eng |
hcfmusp.relation.reference | Sabbah HN, 2012, CURR CARDIOL REP, V14, P326, DOI 10.1007/s11886-012-0265-y | eng |
hcfmusp.relation.reference | Sabbah HN, 2011, CIRC-HEART FAIL, V4, P65, DOI 10.1161/CIRCHEARTFAILURE.110.955013 | eng |
hcfmusp.relation.reference | Sterne JAC, 2016, BMJ-BRIT MED J, V355, DOI 10.1136/bmj.i4919 | eng |
hcfmusp.relation.reference | Wachter R, 2017, EUR HEART J, V38, P301 | eng |
hcfmusp.relation.reference | Wang CB, 2018, CLIN EXP HYPERTENS, V40, P501, DOI 10.1080/10641963.2016.1273943 | eng |
hcfmusp.relation.reference | Weaver FA, 2016, SEMIN THORAC CARDIOV, V28, P320, DOI 10.1053/j.semtcvs.2016.04.017 | eng |
hcfmusp.relation.reference | Zile MR, 2015, EUR J HEART FAIL, V17, P1066, DOI 10.1002/ejhf.299 | eng |
hcfmusp.relation.reference | Zucker IH, 2007, HYPERTENSION, V50, P904, DOI 10.1161/HYPERTENSIONAHA.107.095216 | eng |
dc.description.index | MEDLINE | eng |
hcfmusp.citation.scopus | 7 | - |
hcfmusp.scopus.lastupdate | 2024-03-29 | - |
Appears in Collections: | Artigos e Materiais de Revistas Científicas - HC/InCor Artigos e Materiais de Revistas Científicas - LIM/59 Artigos e Materiais de Revistas Científicas - ODS/03 |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
art_SCHMIDT_Safety_and_efficacy_of_baroreflex_activation_therapy_for_2020.PDF | publishedVersion (English) | 1.26 MB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.